Development Level

Tbio 4 | 10,625
Tclin 3 | 602
Tdark 1 | 7,003

Disease

Cancer 7 | 2,346
glioblastoma 7 | 5,572
osteosarcoma 7 | 7,933
ovarian cancer 7 | 8,484
intraductal papillary-mucinous neoplasm (IPMN) 6 | 3,289
invasive ductal carcinoma 6 | 2,950
lung adenocarcinoma 6 | 2,713
ulcerative colitis 6 | 2,087
lung cancer 5 | 4,466
pancreatic cancer 5 | 2,300
psoriasis 5 | 6,685
Myocardial Ischemia 4 | 169
atypical teratoid / rhabdoid tumor 4 | 4,369
cystic fibrosis 4 | 1,665
diabetes mellitus 4 | 1,663
group 4 medulloblastoma 4 | 1,875
interstitial cystitis 4 | 2,299
intraductal papillary-mucinous adenoma (IPMA) 4 | 2,956
malignant mesothelioma 4 | 3,162
non-small cell lung cancer 4 | 2,798
pilocytic astrocytoma 4 | 3,086
posterior fossa group A ependymoma 4 | 1,511
primary pancreatic ductal adenocarcinoma 4 | 1,271
Age related macular degeneration 3 | 84
Alzheimer's disease 3 | 644
Breast cancer 3 | 3,094
Capillary hemangioma 3 | 11
Cerebral Hemorrhage 3 | 27
Colonic Neoplasms 3 | 126
Coronary artery disease 3 | 240
Diabetic Retinopathy 3 | 53
Heart disease 3 | 279
Hemangioma 3 | 35
Hemangiosarcoma 3 | 18
Hypertension 3 | 287
Keratitis 3 | 42
Kidney disease 3 | 396
Limb ischemia 3 | 12
Osteochondrodysplasias 3 | 15
Pick disease 3 | 1,893
Retinopathy of prematurity 3 | 21
adrenocortical carcinoma 3 | 1,427
adult high grade glioma 3 | 2,148
astrocytic glioma 3 | 2,241
hepatocellular carcinoma 3 | 532
interstitial lung disease 3 | 291
intraductal papillary-mucinous carcinoma (IPMC) 3 | 2,988
medulloblastoma, large-cell 3 | 6,234
non-small cell lung carcinoma 3 | 413
oligodendroglioma 3 | 2,849
pituitary cancer 3 | 1,972
Adenocarcinoma 2 | 115
Atherosclerosis 2 | 275
Carcinoma 2 | 2,147
Carcinoma of thyroid 2 | 17
Cardiovascular system disease 2 | 194
Cerebrovascular disease 2 | 231
Colorectal Neoplasms 2 | 217
Diabetes Mellitus, Experimental 2 | 106
Diabetes Mellitus, Non-Insulin-Dependent 2 | 157
Diabetic Nephropathy 2 | 37
Diarrhea 2 | 155
Down syndrome 2 | 548
Epilepsy, Temporal Lobe 2 | 23
Exanthem 2 | 39
Follicular thyroid carcinoma 2 | 11
Gastrointestinal stromal tumor 2 | 61
Hamman-Rich syndrome 2 | 35
Liver Cirrhosis 2 | 101
Liver cell carcinoma 2 | 15
Macular degeneration 2 | 41
Mammary Neoplasms 2 | 410
Mammary Neoplasms, Experimental 2 | 150
Metastasis from malignant tumor of colon 2 | 8
Neoplasm Metastasis 2 | 138
Neutropenia 2 | 78
Obesity 2 | 616
Ovarian hyperstimulation syndrome 2 | 15
Pancreatic Neuroendocrine Tumor 2 | 45
Papillary thyroid carcinoma 2 | 37
Pathologic Neovascularization 2 | 6
Peripheral vascular disease 2 | 90
Prostatic Neoplasms 2 | 471
Proteinuria 2 | 63
Renal Cell Carcinoma 2 | 199
Reperfusion Injury 2 | 84
Rheumatoid Arthritis 2 | 1,160
Sarcoma of soft tissue 2 | 11
Schizophrenia 2 | 501
Thrombocytopenia 2 | 105
Uremia 2 | 19
active ulcerative colitis 2 | 477
breast carcinoma 2 | 1,614
chronic rhinosinusitis 2 | 512
facioscapulohumeral dystrophy 2 | 286
gastric cancer 2 | 430
mucosa-associated lymphoid tissue lymphoma 2 | 480
pediatric high grade glioma 2 | 2,712
tuberculosis 2 | 1,557
urothelial carcinoma 2 | 318

Tissue

Blood and immune system 8 | 17,995
Cardiovascular System 8 | 17,958
Digestive Tract 8 | 18,473
Endocrine System 8 | 18,512
Female tissues 8 | 18,647
Liver and Pancreas 8 | 18,136
Male tissues 8 | 17,969
Nervous System 8 | 18,561
Respiratory system 8 | 17,484
Skin and soft tissues 8 | 18,115
Urinary Tract 8 | 18,444

Target Family

Non-IDG 3 | 11,971
Transcription Factor 3 | 1,400
Kinase 2 | 634

Grant Application

1R01CA098234-01 8 | 8
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Cytochrome c CYCS Tbio Non-IDG -3.73952 4771.4 630
Vascular endothelial growth factor receptor 1 FLT1 Tclin Kinase -3.34036 2061.0 806
Vascular endothelial growth factor A VEGFA Tclin Non-IDG -4.21581 17832.7 1361
Prominin-1 PROM1 Tbio Non-IDG -3.25267 1922.5 226
Vascular endothelial growth factor receptor 2 KDR Tclin Kinase -3.61849 4236.1 2079
Zinc finger protein 90 homolog ZFP90 Tdark Transcription Factor -1.22577 15.9 48
DNA-binding protein inhibitor ID-1 ID1 Tbio Transcription Factor -2.58672 414.3 295
DNA-binding protein inhibitor ID-3 ID3 Tbio Transcription Factor -2.31653 215.8 367